Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Sci. STKE, 30 August 2005
Vol. 2005, Issue 299, p. tw312
[DOI: 10.1126/stke.2992005tw312]


CANCER AND IMMUNITY Regulated Regulation in Immune Responses

The activity of regulatory T cells (T-reg) is responsible for controlling aberrant immune responses and autoimmunity, but these cells represent a potential barrier to certain types of therapeutic manipulation, such as in cancer immunotherapy. Peng et al. provide evidence that part of human T-reg control may be mediated directly by an innate signaling protein. Clones of human T-reg, as well as isolated naturally occurring T-reg cells, expressed Toll-like receptor (TLR) 8. Ligands that could activate this receptor reversed the suppressive activity of these cells in culture, as well as in a mouse tumor model. Control over T-reg activity by TLR signals may open new avenues for inhibiting unwanted immune suppression during cancer immunotherapy.

G. Peng, Z. Guo, Y. Kiniwa, K. s. Voo, W. Peng, T. Fu, D. Y. Wang, Y. Li, H. Y. Wang, R.-F. Wang, Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309, 1380-1384 (2005). [Abstract] [Full Text]

Citation: Regulated Regulation in Immune Responses. Sci. STKE 2005, tw312 (2005).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882